Midcareer Investigator Award in Patient-Oriented Research: Yael Schenker, MD, MAS
以患者为导向的研究中的职业生涯中期研究员奖:Yael Schenker,医学博士,MAS
基本信息
- 批准号:10592288
- 负责人:
- 金额:$ 18.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdvanced Malignant NeoplasmAgeAgingAttentionAwardBehavior TherapyCaregiver BurdenCaregiversCaringChronicClinicalClinical InvestigatorCognitionCollaborationsCommunicationCompassionComputerized Medical RecordDataData SetDedicationsDiagnosisDisciplineDiseaseEducational CurriculumElderlyEnrollmentEnvironmentFacultyFamily CaregiverFosteringFoundationsFundingFutureGeriatric AssessmentGeriatricsGoalsGrantInfrastructureInterventionIntervention StudiesIntervention TrialInvestigationLearningMalignant NeoplasmsMentorsMentorshipMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchModelingMorbidity - disease rateOffice NursingOlder PopulationOncologyOutcomePalliative CarePatientsPersonal SatisfactionPoliciesPopulationPositioning AttributePostdoctoral FellowPragmatic clinical trialPublic HealthQuality of CareQuality of lifeReportingResearchResearch PersonnelResearch TrainingResourcesRoleSocial supportStudentsTechniquesTestingThinkingTimeTrainingUniversitiesUpdateVisitWorkage relatedcare deliverycare seekingcareercareer developmentdesignexperienceimprovedimproved outcomeinnovationlongitudinal datasetmedical specialtiesmindfulnessnext generationnovelolder patientoutreachpalliativepreferenceprofessorprogramsresilienceskillsstudent mentoringtherapy designtherapy developmenttrial design
项目摘要
ABSTRACT: The growing population of older adults with advanced cancer experiences significant
public health problems, including steep declines in quality of life, receipt of care that does not reflect
patients' values and preferences, and high rates of caregiver burden. Inadequate attention to patient
priorities and age-related concerns (e.g., function, cognition, and social support)—contribute to
morbidity in this population. The emerging field of geriatric palliative care seeks to address age-related
concerns and align care with patient goals over the trajectory of chronic and serious illness. The
overarching goal of this K24 proposal is to enhance the candidate's mentorship of students, fellows,
and junior faculty pursuing geriatric palliative care research, with a particular focus on identifying unmet
geriatric palliative care needs and developing and testing interventions to improve quality of life and
goal-concordant care for older patients with advanced cancer. As a successful mid-career investigator
with a track record of leading successful palliative intervention trials with seriously ill older patients, the
candidate is well-positioned to mentor the next generation of aging researchers. This award will
leverage an outstanding longitudinal dataset of over 400 audio-recorded `primary' palliative care visits
with older patients with advanced cancer and longitudinal patient- and caregiver-reported outcomes to
explore optimal geriatric palliative care intervention designs. The research aims are to (1) characterize
communication about age-related concerns in primary palliative care visits with older adults with
advanced cancer and their family caregivers; (2) identify missed opportunities for addressing age-
related concerns in primary palliative care visits for older adults with advanced cancer and their family
caregivers; and (3) refine a conceptual model for primary palliative care delivery that incorporates age-
related concerns and can be optimized to improve quality of life for older adults with advanced cancer.
The K24 award will provide protected time for the candidate to update and expand her mentorship
program, building bridges between researchers in geriatrics, palliative care and oncology. She will
leverage outstanding aging research and mentoring resources available at the University of Pittsburgh;
learn new skills to foster inquiry, wellbeing and resilience among trainees; and create a Junior Faculty
Visiting Professor Program for geriatric palliative care researchers. This proposal is significant and
innovative because it will support new clinical investigators using novel mentoring techniques and
develop pilot data to inform large-scale trials addressing deficiencies in quality of care for a burgeoning
population of older adults with advanced cancer. It is highly feasible because the candidate is a
committed mentor with ongoing R01 funding, from an outstanding research environment with strong
geriatrics programs and a large pool of potential mentees.
摘要:患有晚期癌症经历的老年人不断增长
公共卫生问题,包括生活质量的急剧下降,收到不反映的护理
患者的价值和偏好,以及伯恩(Burnen)的高照顾者。注意患者的注意力不足
优先事项和与年龄有关的问题(例如功能,认知和社会支持) -
该人群的发病率。老年姑息治疗的新兴领域旨在解决与年龄有关的问题
关注和使护理与患者目标有关慢性病和严重疾病的轨迹。
这项K24提案的总体目标是增强候选人对学生,研究员的心态
和从事老年姑息治疗研究的初级教师,特别着眼于识别未满足
老年姑息治疗需求以及制定和测试干预措施以改善生活质量和
针对老年晚期癌症患者的目标符合护理。作为成功的中期调查员
具有领先的成功姑息干预试验的记录,与年龄较大的患者进行
候选人的位置很好,可以指导下一代老龄化研究人员。这个奖项将
利用超过400个音频录制的“主要”姑息治疗访问的未出色纵向数据集
老年患者患有晚期癌症和纵向患者和护理人员报告的结果
探索最佳的老年姑息治疗干预设计。研究目的是(1)表征
与老年人初级姑息治疗访问中有关年龄有关的问题的沟通
晚期癌症及其家庭护理人员; (2)确定未解决年龄的机会 -
针对晚期癌症老年人及其家人的初级姑息治疗访问的相关问题
照顾者; (3)完善一个主要姑息治疗交付的概念模型,该模型结合了年龄 -
相关问题,可以优化以改善晚期癌症老年人的生活质量。
K24奖将为候选人提供受保护的时间更新和扩展她的精神训练
计划,在老年医学,姑息治疗和肿瘤学领域的研究人员之间建造桥梁。她会的
利用匹兹堡大学获得的杰出老龄化研究和心理资源;
学习新技能,以培养学员的询问,福祉和韧性;并创建一个初级教师
老年姑息治疗研究人员的客座教授计划。该提议很重要,
创新,因为它将使用新颖的心理技术支持新的临床研究人员
制定试点数据,以告知大规模试验,以解决水牛的护理质量缺陷
老年人患有晚期癌症的人群。这是非常可行的,因为候选人是
从持续不断的R01资金进行精神上的精神,来自杰出的研究环境
老年医学计划和大量潜在月经。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yael Schenker其他文献
Yael Schenker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yael Schenker', 18)}}的其他基金
Midcareer Investigator Award in Patient-Oriented Research: Yael Schenker, MD, MAS
以患者为导向的研究中的职业生涯中期研究员奖:Yael Schenker,医学博士,MAS
- 批准号:
10390440 - 财政年份:2021
- 资助金额:
$ 18.46万 - 项目类别:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
针对死亡或严重残疾风险高的危重老年人的专业姑息治疗与重症监护相结合的随机试验
- 批准号:
10663861 - 财政年份:2020
- 资助金额:
$ 18.46万 - 项目类别:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
针对死亡或严重残疾风险高的危重老年人的专业姑息治疗与重症监护相结合的随机试验
- 批准号:
10256820 - 财政年份:2020
- 资助金额:
$ 18.46万 - 项目类别:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
针对死亡或严重残疾风险高的危重老年人的专业姑息治疗与重症监护相结合的随机试验
- 批准号:
10437935 - 财政年份:2020
- 资助金额:
$ 18.46万 - 项目类别:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
针对死亡或严重残疾风险高的危重老年人的专业姑息治疗与重症监护相结合的随机试验
- 批准号:
10030184 - 财政年份:2020
- 资助金额:
$ 18.46万 - 项目类别:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Clinically Ill Older Adults at High Risk of Death or Severe Disability - Supplement
针对死亡或严重残疾高风险的临床疾病老年人的专业姑息治疗与重症监护相结合的随机试验 - 补充
- 批准号:
10714105 - 财政年份:2020
- 资助金额:
$ 18.46万 - 项目类别:
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial
以患者为中心且有效的癌症预先护理计划:PEACe 比较有效性试验
- 批准号:
10401346 - 财政年份:2019
- 资助金额:
$ 18.46万 - 项目类别:
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial
以患者为中心且有效的癌症预先护理计划:PEACe 比较有效性试验
- 批准号:
10569584 - 财政年份:2019
- 资助金额:
$ 18.46万 - 项目类别:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
针对晚期癌症患者进行初级姑息治疗干预 (CONNECT) 的整群随机试验
- 批准号:
9103638 - 财政年份:2016
- 资助金额:
$ 18.46万 - 项目类别:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
针对晚期癌症患者进行初级姑息治疗干预 (CONNECT) 的整群随机试验
- 批准号:
9268708 - 财政年份:2016
- 资助金额:
$ 18.46万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Hawaii Pacific Islands Mammography Registry
夏威夷太平洋岛屿乳腺X线摄影登记处
- 批准号:
10819068 - 财政年份:2023
- 资助金额:
$ 18.46万 - 项目类别:
Targeting PLK1 signaling for the treatment of fibrolamellar carcinoma
靶向 PLK1 信号传导治疗纤维板层癌
- 批准号:
10742683 - 财政年份:2023
- 资助金额:
$ 18.46万 - 项目类别:
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer
促进压力管理复原力 (PRISM) 干预:一项针对患有晚期癌症的青少年和年轻人的多中心随机对照试验
- 批准号:
10895146 - 财政年份:2023
- 资助金额:
$ 18.46万 - 项目类别:
Facilitating Advance Care Planning Discussions Between Patients with Advanced Cancer and Their Family Caregivers Using a Resilience-Building Intervention
使用增强复原力的干预措施促进晚期癌症患者及其家庭护理人员之间的预先护理计划讨论
- 批准号:
10661890 - 财政年份:2023
- 资助金额:
$ 18.46万 - 项目类别: